Browse studies

Find your next paid study

1 recruiting study matching your filters

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia: a Randomized, Double-blind, Placebo-controlled Trial

Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high…

Type 1 Hyperlipoprotenemia

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT05816343